WallStreetZenWallStreetZen

NASDAQ: NEUP
Neuphoria Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Neuphoria Therapeutics revenue was N/A for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $9.5M, up 2,206.4% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, NEUP annual revenue was $0.0, with N/A growth year-over-year.

NEUP revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

Be the first to know when NEUP announces revenue.

NEUP Revenue History By Year

NEUP Yearly RevenueNEUP RevenueNEUP ChangeNEUP Revenue Growth
2024-06-30$0.00N/AN/A
2023-06-30$0.00-$183.08k-100.00%
2022-06-30$183.08kN/AN/A
2021-06-30$0.00-$32.18k-100.00%
2020-06-30$32.18kN/AN/A

1 of 1

Neuphoria Therapeutics Revenue FAQ

What was NEUP's revenue last quarter?

Neuphoria Therapeutics (NASDAQ: NEUP) reported Q1 2025 revenue of $9.49 million up Infinity% year over year. In the same quarter last year, Neuphoria Therapeutics's revenue was $0.00.

What was Neuphoria Therapeutics's revenue in 2024?

Neuphoria Therapeutics's annual revenue for the twelve months ending Jun 30, 2024 was $0.00, a N/A decrease year over year.

How much does Neuphoria Therapeutics make in a day?

Based on Neuphoria Therapeutics annual revenue for the past four years, NEUP makes an average of $125.40 per day.

What was Neuphoria Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Neuphoria Therapeutics's revenue has grown null year over year. Neuphoria Therapeutics's revenue in the past year totaled N/A.

How much does Neuphoria Therapeutics make in a year?

Neuphoria Therapeutics's revenue by year for the past four years is:
  • Neuphoria Therapeutics's revenue for the twelve months ending Jun 30, 2024 was $0.00, a N/A decrease year over year.
  • Neuphoria Therapeutics's annual revenue for Jun 30, 2023 was $0.00, a 100% decrease from 2022.
  • Neuphoria Therapeutics's annual revenue for 2022 was $183.08 thousand, a Infinity% increase from 2021.
  • Neuphoria Therapeutics's annual revenue for 2021 was $0.00, a 100% decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.